Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Mouse RARB (aa 429-448), Synthetic Peptide, Invitrogen™

Synthetic Peptide

Manufacturer:  Invitrogen PEP005

Catalog No. PEP005


Add to cart

Description

Description

Mouse Retinoic Acid (residues 429-448) Synthetic Peptide, PEP-005, from Invitrogen.

PEP-005 is a synthetic peptide whose sequence is from the C-terminal end of the mouse retinoic acid receptor beta (RAR*). The 21 amino acid sequence extends from amino acids 429 to 448 of RAR*. The sequence of PEP-005 is (amino to carboxy terminus): P S V S P S S V E N S G V S Q S P L L Q (The N-terminal cysteine has been added to facilitate conjugation and is not a part of the native mouse RAR* sequence)This peptide may be used for neutralization and control experiments with the monoclonal and polyclonal antibodies that reacts with this product and the human and mouse RAR*, catalog # MA1-811 and PA1-811. Using a solution with equal weights per unit volume of peptide and corresponding antibody will yield a solution with a large molar excess of peptide that is able to competitively bind the antibody.Reconstitute with 0.1 ml of distilled water.
Specifications

Specifications

Synthetic Peptide
purified
50μg
Control
peptide with no preservative
P S V S P S S V E N S G V S Q S P L L Q
RUO
No preservative
Rarb
Control
218772
Mouse
0.5 mg/mL
Lyophilized
Y
Mouse
-20° C, Avoid Freeze/Thaw Cycles
Mouse RARB (aa 429-448)
P22605
Peptide
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit